# Korean Gynecologic Oncology Group

Source: https://onco.cc/companies/kgog/  
OnCo record `kgog` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

The Korean Gynecologic Oncology Group is the Korean incorporated association that runs gynaecological cancer trials; in OnCo it leads a phase 2 study of progestin with a levonorgestrel intrauterine system for fertility-sparing treatment of early endometrial cancer.

## Summary

The Korean Gynecologic Oncology Group (KGOG, 사단법인 대한부인종양연구회) is an incorporated association with its office at Yeongil Building, 32 Nambusunhwan-ro 333-gil, Seocho-gu, Seoul (kgog.org, which also lists its semi-annual meetings). No founding year is stated on the pages read. ClinicalTrials.gov names it lead sponsor (OTHER class) of NCT01594879 (phase 2, medroxyprogesterone acetate with a levonorgestrel-releasing intrauterine system in young women with early endometrial cancer), the trial recorded in OnCo. It has no products of its own.

## Fields

- Kind: Company
- Last checked: 2026-09-25
- Also known as: KGOG; 대한부인종양연구회
- Tags: ctgov-sponsor; cooperative-group
- HQ: Seoul
- Type: cooperative-group
- Website: https://www.kgog.org

## Sources

- Official website: https://www.kgog.org
- ClinicalTrials.gov: trials led by Korean Gynecologic Oncology Group: https://clinicaltrials.gov/search?lead=Korean%20Gynecologic%20Oncology%20Group

## Connected records

- cancers: [Endometrial cancer](https://onco.cc/cancers/endometrial/)
- trials: [Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer](https://onco.cc/trials/nct01594879/)

---
JSON: https://onco.cc/api/v1/entities/kgog.json